4 Papers
1 Citations
Yu Isoshima is an academic researcher from University of Occupational and Environmental Health Japan. The author has contributed to research in topics: Medicine & Cancer. The author has co-authored 1 publications.
Chat about Author
Papers
Avelumab-induced Pneumonitis in Metastatic Merkel Cell Carcinoma
TL;DR: A 78-year-old Japanese woman diagnosed with Merkel cell carcinoma of the left forearm and treated by surgical excision received two cycles of avelumab, an anti-programmed death-ligand 1 monoclonal antibody and developed worsening dyspnea after chemotherapy.
[A Case of Left Upper Lobe Lung Cancer Successfully Diagnosed by Transesophageal Endoscopic Ultrasound with Bronchoscope-Guided Fine Needle Aspiration Alone].
Kazuki Nemoto,Keigo Uchimura,Sachika Hara,Yosuke Chiba,Yu Isoshima,Hidenori Ohira,Yasuyuki Higashi,Masahiro Tahara,Kazuhiro Uyama,Takashi Tachiwada,Shingo Noguchi,Kei Yamasaki,Toshinori Kawanami,Kazuhiro Yatera +13 more
TL;DR: A 58-year-old Japanese woman with fever and cough who was successfully diagnosed as having lung cancer by EUS-B-FNA alone alone is shown, and respiratory physicians should be aware of being skillful at performing E US-B -FNA to accurately and effectively approach target lesions.
Fatal limbic encephalitis as paraneoplastic neurological syndrome in a patient with lung adenocarcinoma positive for antiamphiphysin antibody after durvalumab treatment
Yuto Iwanaga,Takako Kawaguchi,Kei Yamasaki,Toshiki Morimoto,Yu Isoshima,Yosuke Sasahara,Takeshi Orihashi,Kazuhiro Yatera +7 more
TL;DR: In this paper , a 69-year-old Japanese male with advanced lung adenocarcinoma developed neurological symptoms after chemoradiotherapy and durvalumab maintenance therapy.
A Case Report on Pericardial Effusion Associated With Selpercatinib in the First Patient With Rearranged During Transfection (RET) Fusion-Positive Lung Cancer
Tomoko Shiraishi,Yu Isoshima,Masahiro Tahara,Takanobu Jotatsu,Kazuhiro Yatera +4 more